Delpor Appoints Jay Smith as Chief Commercial Officer to Lead Commercialization of Once-Yearly Risperidone Implant

Smith will also be responsible for optimizing customer experience for Delpor’s implant products, as he oversaw over 23k procedures for another implant biotech BRISBANE, CA, March 31, 2021 — Delpor, Inc. (Delpor), a clinical stage [...]